Stephens Inc. AR raised its holdings in Metlife Inc (NYSE:MET) by 2.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 144,058 shares of the financial services provider’s stock after acquiring an additional 3,600 shares during the quarter. Stephens Inc. AR’s holdings in Metlife were worth $7,155,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Old Port Advisors boosted its position in shares of Metlife by 4.1% during the second quarter. Old Port Advisors now owns 4,996 shares of the financial services provider’s stock worth $252,000 after purchasing an additional 199 shares in the last quarter. Unison Advisors LLC raised its holdings in shares of Metlife by 1.0% during the second quarter. Unison Advisors LLC now owns 21,133 shares of the financial services provider’s stock worth $1,049,000 after acquiring an additional 200 shares during the period. Citizens Financial Group Inc RI raised its holdings in shares of Metlife by 12.7% during the first quarter. Citizens Financial Group Inc RI now owns 1,945 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 219 shares during the period. YorkBridge Wealth Partners LLC raised its holdings in shares of Metlife by 2.7% during the first quarter. YorkBridge Wealth Partners LLC now owns 8,566 shares of the financial services provider’s stock worth $365,000 after acquiring an additional 224 shares during the period. Finally, Parkside Financial Bank & Trust raised its holdings in shares of Metlife by 14.0% during the first quarter. Parkside Financial Bank & Trust now owns 1,849 shares of the financial services provider’s stock worth $79,000 after acquiring an additional 227 shares during the period. 75.13% of the stock is currently owned by hedge funds and other institutional investors.

MET stock traded up $0.16 during midday trading on Thursday, hitting $45.03. The company’s stock had a trading volume of 243,022 shares, compared to its average volume of 5,590,369. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.22. Metlife Inc has a twelve month low of $37.76 and a twelve month high of $51.16. The business has a fifty day moving average price of $49.23. The firm has a market cap of $42.97 billion, a PE ratio of 8.36, a P/E/G ratio of 0.97 and a beta of 1.09.

Metlife (NYSE:MET) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.07. Metlife had a net margin of 9.28% and a return on equity of 9.75%. The firm had revenue of $16.45 billion for the quarter, compared to analyst estimates of $16.43 billion. During the same period in the previous year, the business earned $1.30 EPS. The company’s revenue was down 22.4% compared to the same quarter last year. As a group, equities research analysts forecast that Metlife Inc will post 5.65 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Tuesday, August 6th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $1.76 annualized dividend and a yield of 3.91%. Metlife’s payout ratio is currently 32.65%.

A number of brokerages recently commented on MET. Wells Fargo & Co raised their price objective on shares of Metlife from $55.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, July 11th. Morgan Stanley raised their price objective on shares of Metlife from $52.00 to $53.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 10th. Barclays raised their price objective on shares of Metlife from $52.00 to $55.00 and gave the stock an “overweight” rating in a report on Wednesday, May 22nd. Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price objective on the stock in a report on Friday, August 2nd. Finally, ValuEngine lowered shares of Metlife from a “hold” rating to a “sell” rating in a report on Thursday, August 1st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $50.91.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: Why are percentage gainers important?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.